Resources
The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Gene Therapy Development
Post-Event Proceedings – Gene Therapy Development & Manufacturing 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Gene Therapy Development & Manufacturing 2023.
Gene Therapy Development
Curing HIV with cell & gene therapy?
It is now possible to live a long and near normal life with HIV, but what is the likelihood of a permanent cure?
Gene Therapy Development
Safety in Viral Vectors and Viral Clearance: Ensuring Efficacy and Security in Biopharmaceuticals
We discuss the challenges and safety measures in using viral vectors for gene therapies, focusing on vector selection, safety testing, quality control, and contamination prevention, highlighting their importance for the success of advanced medical treatments.
Gene Therapy Development
Viral Vectors in Molecular Biology and Gene Therapy
Adeno-associated viral (AAV) vectors dominate gene therapy due to their efficiency and safety, although challenges remain in addressing toxicity and expanding applications.
Gene Therapy Development
Innovation Hubs for Gene Therapies: Advancing the Academic-Led Clinical Development of Novel Gene Therapies
The UK's cell and gene therapy sector is on the threshold of becoming a global leader in the field. While present challenges include the supply of equipment and skills gaps, Innovation Hubs aim to bridge these through collaboration.
Gene Therapy Development
Replacing the EU's Clinical Trials Directive: A Sea Change in Clinical Trial Execution
The EU's Clinical Trials Regulation has replaced the union's former Clinical Trials Directive, introducing a centralised application process which aims to ensure consistent timelines for clinical trial reviews.
Gene Therapy Development
Tracking Fibonacci Spirals in Plant Evolution and Morphology
Examples of Fibonacci spirals in nature include monkey puzzle trees, the double helix of human DNA, and even certain atmospheric patterns. Now, a new study from the University of Edinburgh suggests that the presence of these patterns in early plants may not be as ubiquitous as previously thought.
Gene Therapy Development
Biocair - Delivering Personalised Supply Chains for Autologous Cell Therapies
Gene Therapy Development
Localising Lentiviral Transduction-Inserted CAR Cassettes in T Cells Using Xdrop
Gene Therapy Development
Professional Assay Services Offers GCLP-Compliant RNAscope, BASEscope, and miRNAscope
Gene Therapy Development
Revealing and Retrieving Highly Potent IFN-y Secretors Using an Xdrop Single-Cell Format Workflow
Gene Therapy Development
Wilhelm Johannsen, Beans, and the Origins of Genotype and Phenotype
We spend a lot of time discussing new cell and gene therapies, as well as their implications for future treatment. But where did the term ‘gene' come from?
Gene Therapy Development
Approved Gene Therapy Products Brought to Market Through the use of AI
Many of the biggest roadblocks in gene therapy development can be removed by tapping into longitudinal datasets facilitated by AI techniques and machine learning, tracking the real-world progress of clinical trial participants.
Gene Therapy Development
CGT Manufacturing: Key Considerations for Implementing AI/ML Approaches
AI/ML approaches are not some miracle ‘one size fits all' fix-all for delays and holdups in CGT manufacture, but the proper implementation of deep learning approaches and data interpretation may help speed up development.
Gene Therapy Development
FDA Pursues Accelerated Approval Path Following Cell and Gene Therapy Backlog
The announcement comes with the news that the cell and gene therapy manufacturing market is now worth US$ 19.3 billion, with a compound annual growth rate (CAGR) of 29% between 2022 and 2023.
Gene Therapy Development
Fortunes Brighten for Bluebird Bio as Cash Runway Extended to 2024
After a rocky year, bluebird bio's approval journey for a treatment for sickle cell disease looks to be back on track, with the company generating more funds by selling shares.
Gene Therapy Development
Abundant Stochastic Off-Target Activity by Base Editors
Can complementary approaches for off-target quantification demonstrate substantial levels in various state-of-the-art editors?
Gene Therapy Development
When to Cut and When to Inhibit? A Low-Throughput, Hands-On Investigation Of CRISPR-Cut and CRISPRi Efficiencies In iPSC And Neural Cells
Gene knockdown – the manual reduction of a particular gene's expression in target cells – entails the modification of cellular development in young cells. CRISPR gene editing techniques enable researchers such as Pia Johansson to induce gene knockdown in target cells.
Gene Therapy Development
Overcoming the Challenges of Precision Genome Editing
Experts from academia and industry discuss the current obstacles and opportunities for genome editing during a roundtable session at Gene Therapy Development & Manufacturing: In-Person.
Gene Therapy Development
Refining Analytics for Gene Delivery Systems
Key opinion leaders from Roche and Purespring Therapeutics debate future strategies for advancing cell and gene therapeutics.
Gene Therapy Development
Daikyo Crystal Zenith® Case Study: Meeting the Challenge of Viral Vector Delivery
Gene Therapy Development
West Pharmaceutical Solutions: Packaging Containment Solutions for Gene Therapy Products
Gene Therapy Development
West Pharmaceutical Solutions: Gene Therapy and Daikyo Crystal Zenith® Vials Case Study
Gene Therapy Development
Inciting Rapid Standardisation in Cell and Gene Therapy Manufacturing
Can the cell and gene therapy field create industry consensus on a more detailed level? In this Insight Article, Jorgen Magnus, Strategic Program Lead of Cell and Gene Therapy at Bayer, highlights the promise of process mapping for reaching a harmonised approach to development and manufacturing standards.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things cell & gene